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INTRODUCTION 
 
Infection as a prime cause or a complication of other illness is the major 
cause of mortality and morbidity throughout the world in neonates. Early 
recognition, diagnosis and treatment of serious infections in the neonates 
are mandatory because of poor defense; newborn cannot localize the 
pathogens, which can easily spread to multiple organs. Lack of 
intervention at an early stage leads to mortality or severe sequelae. 
Progression from mild symptoms to death occurs more rapidly
1
.Most 
neonatal bacterial infections have an early bacteraemic phase preceding 
the development of full blown septicemia or localization of infection in 
organs and tissues. During this phase the clinical signs are subtle, but this 
is when the treatment must be started if there is to be intact survival. 
Neonatal sepsis is classified into early onset sepsis and late onset sepsis.    
Early onset sepsis (EOS): It develops within 72hrs of life. Organisms 
present in genital tract or in labour room and operation theatre are most 
common causes. Most cases are due to gram negative organisms like  
E.Coli, Klebsiella and  Enterobacter species in our country.  
Late onset sepsis (LOS): It develops after 72 hrs of life due to 
community or hospital acquired infection. Two third of LOS is caused by 
gram negative organisms such as Klebsiella pneumoniae, Enterobacter, 
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E.Coli, Pseudomonas aeruginosa, Alcaligenes  faecalis, Salmonella 
typhimurium, Proteus, Citrobacter and Serratia. Rest is caused by gram 
positive organisms such as Coagulase negative staphylococcus (CONS) 
and Staph aureus. 
WHO clinical criteria for the diagnosis of sepsis in young infant
2: 
Convulsion, respiratory rate >60 breaths/min, severe chest indrawing, 
temperature >37.7 degree Celsius or <35.5 degree Celsius, lethargic or 
unconscious, reduced movements, not able to feed, crepitations, cyanosis, 
reduced capillary refill time. 
      In early stages signs are subtle and non specific. Following are 
symptoms and signs of neonatal sepsis. 
Going off: This is the earliest sign often overlooked. Mother or 
experienced nurse thinks baby is not right. Baby may be slightly floppy, 
pale or mottled. The infant may be slightly irritable and poor sucking. 
Temperature changes: A temperature below 36 degree Celsius and 
above 37.8 degree Celsius sustained for more than an hour must be 
regarded as probably due to infection unless proved otherwise
3, 4
. 
Gastrointestinal system: Feeding intolerance, abdominal distension due 
to ileus, vomiting which may contain altered blood and aponea. In 
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preterm baby apnoea attacks are an early and significant sign of all types 
of infection. 
Respiratory system: Tachypnea - Repiratory rate >60/min, Mild 
retraction, cyanosis, grunting, dyspnoea.                                                                           
Cardiovascular system: Tachycardia >160/min
5
, Poor cutaneous 
circulation as evidenced by skin mottling and capillary refilling time > 3 
secs.                                                                                                                                                                          
DIVC (Disseminated intravascular coagulation): In severely ill babies 
with prolonged hypothermia and acidosis, bleeding manifestations may 
appear due to consumptive coagulopathy as a result of disseminated 
intravascular coagulation. There is excessive bleeding from vene 
puncture site, spontaneous ecchymosis, massive pulmonary hemorrhage 
and hemorrhagic cerebral infarcts. 
Sclerema: In advanced moribund case, the skin assumes hide bound 
characteristics and is stretched out over the underlying structure. The 
change begins over skin of the face and legs which becomes unpinchable 
and subsequently skin changes advance centripetally. When skin of chest 
is affected, the breathing movements are interfered resulting in shallow 
rapid breathing and cyanosis
6
.
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In addition to the above features of disseminated infection, localizing 
features may appear depending up on the predominant involvement of 
different systems as discussed below. 
Meningitis: About 5 – 15 % of neonates with septicemia may have 
coexistent meningitis. The evidence of meningeal irritation is generally 
absent in neonates. Therefore high index of suspicion and frequent resort 
to lumbar puncture are essential to make an early diagnosis. In a baby 
with a clinical profile of septicemia, increase in body temperature, onset 
of seizure or twitching,  vacant stare, tense anterior fontanel and irritable 
cry or excessive cry are signs of meningitis. Meningitis is more common 
in late onset septicemia .The presence of meningitis prolongs the course 
of treatment. Late diagnosis and treatment is associated with adverse 
outcome and increased mortality. Ventriculitis is more commonly 
associated, when there is congenital anomaly like meningomyelocele and 
intra ventricular shunt. It is associated with poor clinical or laboratory 
response to antibiotic therapy. Persistent seizure, bulging anterior 
fontanel, increasing head circumference and neck stiffness are suggestive 
of ventriculitis. Sonographic examination would reveal ventricular 
dilatation, increased echogenicity and septum formation. Ventricular tap 
shows more than 100 WBCs/cumm.  CSF examination with Gram 
staining may reveal organism. Culture may yield growth. 
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Pneumonia: May manifest as mild respiratory distress to fulminant 
hemorrhagic pneumonia with shock. Hence it is advisable to take chest x-
ray in babies with neonatal septicemia. Apneic spells with cyanosis, fast 
breathing and crepitations are suggestive of pulmonary involvement. 
Cough is a rare manifestation in newborn babies.                                                                          
  Pyelonephritis: The incidence of urinary tract infection in neonates is 
between 0.1 – 1%. Like sepsis, preterm and male babies are more prone 
to urinary tract infection (UTI). There are generally no symptomatic clues 
for the clinical diagnosis of pyelonephritis. Rarely the kidney may be 
enlarged and palpable. Poor weight gain in spite of adequate feeds may 
be subtle sign of UTI which mandates urinanalysis and to rule out urinary 
tract infection. 
Osteomyelitis and septic arthritis: Bones and joints involvement are 
common. Infection may occur through hematogenous spread or from 
overlying skin directly following venepuncture or overlying skin abscess 
.The bones and joint infection are most common with Staphylococcus 
aureus. But it may also caused by other organism. There are classical 
signs of inflammation like erythema, swelling, tenderness and restriction 
of movements. Septic arthritis is more common in knee, hip and wrist 
joints. Osteomyelitis may occur in any bone. Plain skiagram, ultra 
sonogram, MRI, joint space needle aspiration of pus for gram staining 
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and culture and sensitivity are diagnostic. Treatment consists of surgical 
drainage, local immobilization and prolonged antibiotic course of 4 – 6 
weeks. Parenteral antibiotic should be advocated at least for 4 weeks. 
Disability and growth plate damage which will affect bone growth are 
long term complication.                                                              
Necrotising enterocolitis (NEC): It is more common in preterm infants. 
Perinatal asphyxia is predisposing factor in term pregnancy. There is 
marked abdominal distension, bile stained vomitus and passage of blood 
and mucus per rectum. There will be diminished or absent bowel sounds. 
Abdominal guarding and rigidity may be present due to peritonitis. 
Severe NEC leads to bowel perforation which can be seen as free air 
under the diaphragm in x-ray. An inflammatory mass may be palpable in 
right iliac fossa. Stool examination may reveal occult blood and may be 
positive for reducing substances. X-ray may show pneumatosis 
intestinalis or portal gas shadow. 
Symptoms and signs pertaining to individual organisms 
Gram negative bacilli: In developing countries like India the most 
common cause of both early onset and late onset sepsis is Gram negative 
organisms. These consist of diverse group of organisms of widely 
differing genera. Most of those causing newborn sepsis belong to the 
Enterobacteriaceae family.  The most important organism causing  sepsis 
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in neonates in developing countries are E.coli , Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Serratia marcescesens, Citrobacter diversus, 
Proteus mirabilis and Enterobacter cloacae. Sepsis due to gram negative 
bacilli are usually severe and mortality and morbidity is very high, 
especially among preterm and low birth weight infants. The presence of 
grayish-black gangrenous patches on the skin is indicative of septicemia 
due to Klebsiella and Pseudomonas. The practical utility of this sign is 
limited because it appears rather late during the course of disease. The 
baby is often beyond survival when it appears. The mortality rate for 
pseudomonas sepsis is 23% in India
7
. Colonization of airway by gram 
negative bacilli is usually associated with increased severity of chronic 
lung disease. Cholestatic liver disease can occur in Gram negative 
septicemia. Removal of central venous catheters is a mandatory as a part 
of treatment in most of the cases, particularly when bacteraemia has 
persisted for more than 24 hours or when there is decreased platelet 
count. 
Coagulase negative staphylococcus (CONS): CONS currently is one of 
most common cause for late onset sepsis .The CONS is the normal 
commensal of human skin, where it is found in abundance. They can be 
identified in the skin of some preterm infants as early as 6 hours of age, 
and grows rapidly to colonize all infants’ skin during the first week of 
16 
 
life. The umbilicus and the nose are the most heavily colonized sites. 
Infants who are long-stay NICU patients on ventilators and with central 
venous access are typically infected. Premature infants seem especially 
vulnerable to CONS sepsis, and their inadequacy of complement 
mediated opsonic activity against staph. epidermidis may be one of the 
reason. Sepsis is commonly with slime producing strain
8,9
. Slime is a 
mucinous extracellular polysaccharide substance which helps the 
adherence of organism to smooth surface such as the silicone or plastic 
used for intravascular lines, shunts and endotracheal tubes. Slime also 
prevents neutrophil chemotaxis and phagocytosis and decreases 
blastogenesis. There are also some reports that the slime also prevents the 
action of glycopeptide antibiotics such as vancomycin
10
. 
Most infants present between 7 and 14 days of age. CONS sepsis 
presentation is widely variable. Rarely the baby is acutely ill and present 
with all the signs of fulminant sepsis, but more often the presentation in 
beginning is subtle, even in those with infective endocarditis. Transient 
apnoeic attacks, fast breathing, skin mottling, abdominal distension, 
watery stools, occasional vomitus, a few fever spikes up to 37.6 to 38 
degree Celsius, the requirement of increased ventilator support are 
typical. There is significant association between duration of catheter is in 
place and the risk of infection. Another significant predisposing factor is 
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the number of times the catheter is used for procedures such as giving 
drugs or blood transfusions. The infusion of intravenous lipid 
preparations is an independent predisposing factor to catheter related 
CONS sepsis. 
             Blood count changes are fairly common and include a rise in total 
count and fall in platelet count and hemoglobulin concentration. Fall in 
level of plasma fibronectin level has a remarkably high specificity of 94% 
in suspected late onset septicemia among preterm and very low birth 
weight babies
11
. 
Staphylococcus aureus: Staph aureus is intrinsically far more pathogenic 
than CONS. This is partly due to extracellular factors, particularly the α-
hemolysin, epidermolytic toxin, enterotoxin, coagulase and leucocidin, 
and also by surface component such as techoic acid which offers mucosal 
binding property. Staph aureus remains the commonest cause of infection 
of skin, umbilical cord and bones and joints, and a common cause of 
infection of eye. Systemic sepsis carries high morbidity and mortality 
rates. 
Staph aureus access a foothold very easily, and quantitative reports have 
shown that less than 10 organisms can initiate colonization of the 
umbilicus. Infection with staph aureus needs earlier action if death or 
serious morbidity to be prevented. Pustular or impetiginous lesion are 
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common, which provides a clue to offending organism. Rapid infiltration 
of organisms occurs especially to bones, joints and lungs. Staph aureus is 
a relatively remote cause of meningitis and still rarer cause of urinary 
tract infection. Neonatal Staphylococcal scaled skin syndrome is also 
reported. Blood and other cultures are generally positive within 24 hours 
and decrease in neutrophils and platelets are common. The CRP usually 
rises and values above 100mg/l are often encountered within 12-24 hours 
of illness.      
Group B streptococcus: It is a commensal of GIT and vagina. Most 
cases of GBS sepsis occur within 4 to 6 hours and almost 90% of cases 
present within day of birth.GBS sepsis may herald as severe birth 
asphyxia or occur immediately after resuscitation, with respiratory 
failure, circulatory failure. Very often the baby presents with early signs 
of septicemia. Without early recognition and treatment, the baby’s 
condition detoriates rapidly and needs intubation and IPPV for respiratory 
failure and severe hypoxemia, often showing cardiorespiratory features of 
persistent pulmonary hypertension of the newborn. Fall in blood pressure, 
metabolic acidosis, tachycardia and poor perfusion occur in severe cases, 
then the prognosis is grave. 
        The hypotension, hypoxia, the liver and lung injury that characterize 
early onset GBS sepsis in the newborn are very reminiscent of the 
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systemic inflammatory release syndrome caused by the endotoxins of 
gram negative organisms. Gram negative endotoxins exert its effect 
mainly by stimulating the release of cytokines, such as TNF-α, IL -1 and 
IL -6 from antigen presenting cells, including macrophage and 
monocytes
12
. TNF-α cause progressive hypotension, decreased cardiac 
output, hypoxia and lung injury. TNF-α can be detect in serum and urine 
of babies with GBS sepsis. The cellular component of GBS causing septic 
shock is thought to be β-hemolysin. Another feature of GBS is its ability 
to invade pulmonary endothelial cells, especially the cells of 
microvasculature, and leads to release of the eicasonoids, such as 
prostacyclin and PGE2, which cause increase in pulmonary arterial 
pressure and pulmonary and systemic vascular resistance, and decrease in 
cardiac output and heart rate 
        A baby is most susceptible to GBS when the mother, despite having 
GBS in her vagina, has little or no circulating anti GBS IgG. The blood 
cultures will almost invariably positive if the mother has not been treated 
with antibiotics. Meningitis is relatively unusual in babies presenting in 
the first hour of life. But a lumbar puncture should be performed in 
infants presenting with signs of early onset sepsis. Neutropenia and the 
presence of primitive cells in the peripheral blood are common. 
Neutropenia < 1500/l is an ominous sign. Anemia and thrombocytopenia 
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may develop in survivors. Acute phase reactants such as CRP are 
generally highly elevated in GBS sepsis, but there may be a delay of 12 
hours or so in between onset of signs and rise in CRP. Early acidosis and 
hypotension are bad signs. 
     Approximately 1% of newborn born vaginally to the mother who carry 
GBS at the time of birth become infected. Important predisposing factors 
are chorioamnionitis, prolonged labour, prolonged rupture of membranes, 
frequent pelvic examination in labour and low birth weight. When the 
membranes rupture prior to onset of labour, known simply as premature 
rupture of membrane   (PROM), the interval between membrane rupture 
and the birth of the baby may be prolonged. When the membrane rupture 
at less than 37 weeks gestation – known as preterm premature rupture of 
membrane (PPROM), an even greater interval between membrane rupture 
and child birth often occurs. The risk of neonatal sepsis following 
PPROM has been reported to be about 3.5 times that without PPROM
13
. 
Meconium staining of liquor increases risk of intra amniotic infection. 
Hemophilus influenza: H.influenzae usually non capsulated strain has an 
affinity for the female genital tract. Most newborn present immediately 
after birth with respiratory distress due to pneumonia. Meningitis and 
conjunctivitis are relatively common. The reported mortality is 50%
14
. 
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Ampicillin resistance is emerging and cofotaxime should be added when 
there is reason to suspect H.influenzae. 
Enterococci:  These are mostly non β haemolytic. They are normal bowel 
organisms which only cause disease when they get out of their proper 
place. The organisms causing most disease in babies are Entercoccus 
faecalis and Enterococcus faecium. Enterococci are a notorious cause of 
nosocomial infection in neonatal intensive care units. In the NICU, 
Enterococci are an important cause of serious late onset sepsis among 
VLBW infants. 
Listeriosis: L.monocytogenes is a short gram positive rod which can be 
found both inside and outside cells. The most important reservoir for 
transmission to humans is probably food, especially dairy products, 
contaminated by infected farm animals. Woman infected with HIV are 
more susceptible to L.monocytogenes
15
. Newborn infants are particularly 
susceptible for a variety of immunological reasons, including defect in 
macrophage response and low opsonic activity. 
Three main types of neonatal and fetal infection are found. Transplacental 
infection, early onset infection acquired intrapartum, late onset infection 
usually meningitis probably due to nosocomial infection. 
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Transplacental infection: L.monocytogenes causes non specific 
influenza or gastroenteritic illness in the pregnant woman, during which 
the organism may infect the fetus, either by hematogenous spread across 
the placenta or via infection of the amniotic fluid. First or second 
trimester infection may cause fetal death or miscarriage, and recurrent 
abortion. Later in pregnancy, infection may precipitate preterm labour, 
with fetal distress and meconium staining of liquor. Because meconium 
staining of liquor is rare at gestation below 34 weeks, its presence should 
raise the suspicion of Listeria. Live born babies are extremely ill at birth. 
They may have a severe pneumonia, and hepatomegaly and meningitis 
may already be present. Blood and stool cultures are invariably positive. 
Characteristically, small 2-3 mm pink granulomatous lesions are wide 
spread in the lung, liver, CNS and many other tissue and organs. 
Early onset infection acquired intrapartum : Most cases of neonatal 
listeriosis are sporadic, but epidemics are described. At least two-thirds of 
infants who acquire listeria infection are preterm, and almost all become 
ill within 24 hours of life. Most have disseminated infection with 
pneumonia, meningitis, thrombocytopenia, anaemia and sometimes 
conjunctivitis. Small cutaneous granuloma may be found in some babies. 
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Focal bacterial infection 
Meningitis: Inflammation, edema and arachnoiditis are widespread in 
most cases of neonatal meningitis, as are vasculitis and superficial 
cortical thrombophlebitis, which cause superficial ischemic damage to the 
brain. Ventriculitis occur in 70-90% of cases of neonatal meningitis, but 
it is less common with GBS than with gram negative organisms. Severe 
encephalitic changes often occur, probably as a result of direct 
penetration of organism in to brain, and may result in wide spread 
cerebral atrophy. The choroid plexus may be damaged, permanently 
compromising CSF production, and exudates may obstruct intra 
ventricular foramina and arachnoid granulations, leading to 
hydrocephalus in around one third of the cases. Abscess formation is 
commonly seen with meningitis caused by Citrobacter and Proteus 
species and occasionally with other Coliforms
16
. Abscess formation 
begins with suppurative ventriculitis and progress to periventricular 
abscess formation. 
Urinary tract infection: Infants of cocaine users seems to be unusually 
susceptible to UTI
17
. UTI in newborn is believed to be occurring mainly 
as a result of hematogenous spread of organism to the kidney during the 
septicaemia, although no doubt, the reverse situation can also apply. 
Breast feeding offers a significant degree of protection. 
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The commonest pathogen by far is E.coli, and responsible strains are 
associated with P fimbria, a limited number of serotypes, resistance to 
bactericidal effect of serum, adhesion to the epithelial cell and production 
of hemolysin. In addition many gram negative enteric bacteria and gram 
positive cocci, including CONS, Staph aureus and Enterococci, can cause 
neonatal UTI. Candida albicans accounts for some 40% of UTI in 
neonatal unit setting
18
. In the case of VLBW babies, this is usually one of 
the component of multisystem infection.   
 Investigations 
The decision to treat will be mainly determined by clinical assessment. 
Since septic infants detoriate so rapidly, the threshold for pre-emptive 
strike with antibiotics should be very low. To improve on this diagnostic 
accuracy, various tests have been developed and evaluated. 
Given the limited  predictive power of existing tests, and the fact only 
few of them can produce results rapidly enough, decisions about 
antibiotic prescribing for unwell babies should continue to be made on 
clinical grounds. However, positive test results suggestive of infection 
may be sufficient reason to begin therapy even when the level of clinical 
suspicion is not high. The only test results that are more or less 
immediately available and sufficiently powerful to endorse a decision to 
go ahead with antibiotic therapy are cerebrospinal fluid (CSF) and urine 
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microscopy, bacterial antigen test, Buffy coat microscopy and possibly 
the chest x-ray (CXR). The rest of the tests subserve one or both of the 
following functions. To provide   retrospective evidence for or against the 
clinical diagnosis of infection. To establish the nature and antimicrobial 
sensitivity of infecting organisms. 
Blood culture: This is the definitive test. Virtually all cultures that are 
going to be positive have grown by 48 hours whatever the culture 
method. Possible exceptions are Listeria monocytogenes, H. influenzae 
and yeasts, which may all take longer time to grow. Blood for culture 
should be taken before starting or changing antibiotics. Ideally blood for 
culture should be taken from a peripheral vein after thoroughly cleaning 
the overlying skin with an antiseptic solution and allowing to dry. 
Chlorhexidine with alcohol or an iodine containing solution should be 
used. A better result can be obtained if the skin is cleansed for 30 seconds 
rather than the usual 5-10 seconds. With good technique, the skin 
contamination of blood cultures taken from peripheral veins can be 
reduced to an acceptable level. It is recommended to take 1 ml of blood in 
a 10-20 ml broth or 0.5 ml blood in 5–10 ml broth
19
. Taking two cultures 
from separate site is a way to reduce false positive diagnosis of infection. 
A pure growth appearing with in 24 -48 hours is virtually always 
significant. Mixed organisms, bizarre organisms and growth that do not 
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appear until after 72 hours of incubation should raise suspicion. However, 
in the case of the VLBW infant, it is unwise to ignore bizarre organisms 
or polymicrobial infection. 
CONS present the greatest difficulty, because they colonize the skin of all 
the babies and yet are the commonest pathogen among NICU inmates. 
Multiple site blood culture may improve the distinction between genuine 
septicemia and skin contamination
20
. 
Hematological investigation 
Total white cell count: The total leucocyte count has a low predictive 
value for the diagnosis of sepsis because of wide range of normal count 
from 8000 to 20,000/cumm. Leucopenia, less than 5000/cumm is usually 
associated with neonatal sepsis. 
Absolute neutrophil count: The neutrophil count is of more value.  
Within first 48 hours of life, neutropenia less than 2 – 2.5 × 10⁹/l suggests 
bacterial infection, and at this cut off value the sensitivity is around 20%. 
Thereafter, both neutropenia and neutrophilia have useful predictive 
power, although in neither case is the specificity or sensitivity greater 
than about 80%
21
. 
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Normal neutrophil (×10⁹/l) counts in the first month of life:  
 
 
  
 
Table: 1                                                                                                                                                                      
 
Band form: The appearance of circulating neutrophils changes in 
infection, so that more immature forms are seen in peripheral circulation. 
These are commonly known as band forms. The absolute value for band 
forms is not of much use because it tends to rise late in the infection, and 
in most severely affected infants, band cell production is limited as the 
marrow becomes exhausted. A slightly more useful indicator of infection 
is the ratio of immature to total neutrophil (I/T ratio). The maximum 
normal value is 0.16 during first 24 hours, 0.14 by 48 hours, and 0.13 by 
60 hours, where it remains until 5 days of age. Thereafter, the maximum 
normal I/T ratio is 0.12 until the end of first month. Several studies have 
found that  I/T ratio of > 0.2 is useful marker of neonatal sepsis. An 
abnormal I/T ratio in the presence of low absolute neutrophil count is 
more strongly suggestive of sepsis. 
           AGE          MEAN         RANGE 
       BIRTH         11.1        6 -2 6 
      12 HOURS         15.5        6 - 28 
      24 HOURS         11.5        5 - 21 
      1 WEEK         5.5       1.5 - 10 
      2 WEEKS         4.5       1 - 9.5 
      1 MONTH         3.8       1 - 9  
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Platelet count: In 50 % of babies with bacterial infection, the platelet 
count will fall below 100×10⁹/l, but this usually occurs after the baby is 
obviously septic. In a recent study, the sensitivity and specificity of 
thrombocytopenia for the diagnosis of septicemia were reported as 65% 
and 47% respectively
22
. 
Micro erythrocyte sedimentation rate: Micro-ESR is a simple, 
inexpensive but not very reliable marker of neonatal infection. Normal 
value is up to 6 mm in the first hour during the first 3 day of life. By the 
end of first month, maximum fall may up to 11 mm. During the neonatal 
period value more than 15mm is considered as suggestive of infection. 
Micro-ESR is obtained by collecting capillary blood in a standard pre-
heparinized micro- hematocrit tube (75 mm length, internal diameter of 
1.1 mm and outer diameter 1.5 mm) and by reading the fall of erythrocyte 
column after one hour 
Acridine orange test: Direct staining of microorganism with in WBCs 
using the acridine orange technique is a useful way of diagnosing 
septicemia and fungaemia. Microscopy of a Buffy coat smear stained 
with methylene blue is also a useful test, with a high rate of concordance 
with blood culture results.   
Lumbar puncture (LP): Neonatal bacterial meningitis carries such a 
high mortality and morbidity, especially if the diagnosis and treatment are 
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delayed. A lumbar puncture should be performed as a part of infectious 
disease work up of most ill babies before antibiotics are started. 
Exemptions can be made for babies with pulmonary infections 
complicating long term intermittent positive pressure ventilation, babies 
with overt localized infection such as NEC or osteomyelitis and babies 
who would not tolerate the procedure. However there is a slight risk of 
missing or delaying the diagnosis of meningitis in preterm infants if the 
LP is omitted from early sepsis screening. In general, the LP is more 
likely to produce a positive result in late onset than in early onset sepsis
23
.  
Although high WBC counts in CSF have sometimes been reported in 
babies without meningitis, a polymorphonuclear  count higher than 
20/cumm should be regarded with suspicion, and count above 30/cumm 
are strongly indicative of meningitis. When blood stained CSF is 
obtained, the ratio of red cells to white cells to be calculated. In 
uninfected CSF it is usually > 500:1. Gram negative meningitis generally 
produces a higher CSF white cell count than does GBS meningitis, in 
which the WBC count is often <100/cumm. 
Microscopy of the CSF is crucial and may with caution be used to direct 
the choice of initial antibiotic therapy, although broad spectrum antibiotic 
to be used until the results of the culture are known. The isolation of 
Candida species from the CSF of  infants in the absence of other CSF 
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abnormality usually suggests contamination
24
. If no organisms are seen 
on Gram stain, latex agglutination testing on the CSF will identify GBS 
infection with high degree of specificity. 
The upper normal limit of CSF protein is 1.5-2 g/l in the term baby. 
Preterm often have higher CSF protein concentration but rarely greater 
than 3g/l. The levels are usually raised in meningitis. CSF glucose levels 
should be related to simultaneous measurement of blood glucose. The 
CSF glucose should be at least 50% of the blood glucose level. A low 
level suggests bacterial meningitis. 
The CSF should be tested for the presence of group B streptococcal or 
E.coli K1 antigen, which gives accurate and prompt diagnostic 
information. 
An LP should be performed 48 hours after the completion of antibiotic 
therapy. The last CSF may not show complete clearing of cells, but the 
sugar and protein value should be within the normal range, no organism 
should be seen, the CRP should have fallen to a normal value, and the 
culture should be negative.   
A new development in the diagnosis of meningitis in neonates and infants 
is the measurement of cytokines such as interleukin-6 (IL-6) and tumour 
necrosis factor alpha (TNF-α) in the CSF
25
. A recent study found IL-6 to 
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be present in the CSF of each of 20 infants with bacterial meningitis and 
absent in all 20 infants without bacterial meningitis. In case of aseptic 
meningitis, IL-6 was found in half, but at only about 10% of 
concentration found in bacterial meningitis. More research is needed to 
define the predictive value of tests for neonatal meningitis based on 
cytokine measurements. 
Acute-phase proteins 
C-reactive protein 
CRP is a better indicator of infection than the WBC indices, especially if 
serial measurements are made
26
 and a receiver operator characteristic 
curve is constructed to establish the best cut-off value. It takes several 
hours for the CRP concentration to rise in an infected baby, however, and 
so the CRP is not often of much value in deciding whether to treat with 
antibiotics. The greatest worth of CRP is in the retrospective evaluation 
of a clinical diagnosis of sepsis after starting treatment. Culture grown 
sepsis is unlikely if the CRP does not rise within 24-48 hrs of the onset of 
the illness
27,28,29
, and the combination of a normal CRP and negative 
cultures at 48 hours is a generally safe basis for stopping antibiotic 
therapy which was started on clinical suspicion. Serial measurements of 
CRP are useful in monitoring the progress of infection and may help 
decide for how long to continue treatment.  Persistently elevated CRP 
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during antibiotic therapy for presumed bacterial infection should suggest 
the possibility of fungal infection, resistant organisms, or the 
development of a complication such as bacterial endocarditis or abscess 
formation. A raised CRP is often seen in association with meconium 
aspiration, even when there is no evidence of bacterial infection. 
Other acute phase proteins 
Orosomucoids (α1-acid glycoprotein), haptoglobin, α1-antitrypsin and 
α1-antichymotrypsin have all been used in assessing neonatal infection, 
but add little if anything to what is learnt from studying CRP. The same 
applies to fibronectin assays, although it is worth pointing out that any 
septic preterm infants develop significantly low plasma fibronectin 
concentrations, which may impair their ability to combat infection. 
Serum Procalcitonin: Elevated serum concentrations of procalcitonin 
have recently been shown to predict neonatal sepsis with considerable 
accuracy. Procalcitonin distinguishes between infection and inflammation 
which CRP does not. It differentiates between bacterial and viral 
infection with high specificity. Procalcitonin a precursor of calcitonin, It 
contains 116 amino acids. It is secreted by C cells of thyroid gland in 
normal situation. In bacterial infection it is secreted by infected monocyte 
and macrophage.   Bacterial lipopolysaccharide has been a potent inducer 
of PCT release in to systemic circulation. PCT level start to rise from 3 - 
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4 hrs after an endotoxin challenge and peak about 6 hrs. PCT has half life 
of 25 to 30 hrs
30
.                                         
Cytokines  
TNF-α and IL-6  
Since TNF-α is a principal indicator of systemic inflammation and 
together with IL-6 induces CRP, elevation of TNF-α and IL-6 
concentrations in plasma should provide an early indication of sepsis. IL-
8 is also likely to be an early indicator of sepsis, as it is involved in 
neutrophil release from the bone marrow and neutrophil activation. The 
value of these cytokines as markers of bacterial sepsis is in newborn 
infants has recently been reviewed
31
. 
It appears that IL-6 is a better marker of early-onset sepsis than CRP and 
that combining cytokine and CRP measurements, as well as serial testing, 
improves the accuracy of the tests as the markers of sepsis. Umbilical 
venous IL-6 (but not TNF-α) concentrations have been shown to be 
elevated in every preterm babies with intrauterine or early onset sepsis. 
Serum granulocyte colony stimulating factor 
Using a cut off value of 120pg/ml, the serum G-CSF concentration has 
been shown to have a sensitivity of 95%, a specificity of 73%, a positive 
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predictive value of 40% and a negative predictive value of 99% in the 
diagnosis of culture proven neonatal sepsis
32
. 
Immunological studies 
Antigen detecting tests 
Counter immune electrophoresis has been used to detect the presence of 
bacterial antigens in blood, urine or CSF, but it is little used in neonatal 
practice. However, rapid screening for GBS using latex particle 
agglutination is in quite widespread use for detecting both maternal and 
neonatal colonization. In screening neonates, it has been suggested that it 
may be best to concentrate the urine before testing. However a recent 
evaluation of the test on concentrated urine in screening fort GBS within 
the first 24 hours of life found a sensitivity of 90%, a specificity of 70%, 
a positive predictive value of 12% and a negative predictive value of 
99%
33
. These results suggest that the main value of the test may be in 
providing reassurance of the absence of GBS. 
Genetic techniques 
It is now possible to amplify highly conserved DNA sequences from a 
variety of Gram-positive and Gram-negative organism, as well as many 
viruses, using PCR, while avoiding the simultaneous amplifications of 
associated human DNA34. This method has the potential to be automated 
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and to provide rapid diagnosis of bacteraemia. Other DNA amplification 
techniques are also becoming available. 
Gastric aspirate 
This can be viewed as a sample of amniotic fluid, plus or minus some 
swallowed secretions from the birth canal. About one-third of gastric 
aspirates show bacteria on gram stain (often potential pathogens, such as 
the Enterobacteriaceae, GBS and Enterococci) and a similar proportion 
contain some polymorphs. The great majority of these babies do not 
become septic, and the results of gastric aspirate microbiology cannot be 
considered an argument for antibiotic therapy. If a baby is thought to be 
infected on clinical grounds, however, it is important to choose antibiotic 
therapy that will cover any organisms seen in gastric aspirate. The gastric 
aspirate can only contribute to the diagnosis of infection if taken 
immediately after birth and before the baby has been fed. 
Maternal high vaginal swab 
When babies present with signs of infection within the first 24-48 hours 
of birth, the source is likely to be the maternal vagina, and a high vaginal 
swab (HVS) may well grow the responsible organism. However a low 
vaginal/perinial swab with enrichment media is more likely to yield a 
positive result for GBS. In common with the gastric aspirate and surface 
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swabs, however, the HVS tells about possible exposure to pathogens and 
not about infection, and the results are available too late to influence 
initial decision-making about therapy. They may help, though, to decide 
about the need to continue with therapy and on the choice of therapeutic 
agent. 
Urine 
There are two practical ways to obtain urine from babies for the purpose 
of diagnosing infection. One is to use a urine collection bag and the other 
is to perform a suprapubic aspiration (SPA). SPA overcomes the problem 
of contamination, and pus cells or organisms in a technically satisfactory 
SPA indicate urinary infection. To avoid delay and uncertainty, it may be 
worth performing an SPA in the initial assessment of the sick baby who is 
thought to be septicemic. 
As part of the routine septic screen it is usual to begin with a urine 
specimen collection bag applied to the perineum. The perineum should be 
cleaned carefully before the bag is applied, and the bag should be 
removed as soon as the urine is passed. If bacteria and white cells are 
seen this strongly suggests UTI. Positive bag urines should always be 
viewed with suspicion unless there are many white cells (>150/cumm) 
and a pure growth of at least 10⁸ organisms per liter of urine (10⁵/ml). A 
mixed growth or an organism other than E.Coli, obtained from bag urine 
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should always be confirmed by performing an SPA. It is also possible to 
screen for UTI in babies by means of dipsticks. These measure the 
concentrations of leukocyte esterase, nitrites and protein by a colour 
change which can be read using a photometer. One study has shown a 
negative predictive value for UTI of 99.4% in a cohort of newborn babies 
and infants
35
.   
Tracheal secretions and endotracheal tube tip culture 
The results of cultures of respiratory secretions should therefore be used 
to inform the choice of antimicrobial agents for suspected pulmonary 
infection. However it is naive to base the diagnosis of pulmonary 
infection solely on the results of culture of respiratory secretions as 
illustrated by a recent study comparing tracheal aspirate cultures from 
babies showing signs of respiratory deterioration with cultures from 
babies who were stable. No significant difference was found in the rate of 
positive cultures for bacteria, viruses, Chlamydia or Ureaplasmas. 
Cultures were positive in about one-third babies in each group36. 
Vascular lines and thoracentesis tube  
The tips of umbilical cannulae, central lines and thoracentesis tubes 
should be sent for culture when removed. Central lines can be cultured 
using the ‘Macki roll’ technique in which the line is rolled across the 
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culture plate and a subsequent colony count performed. This can help to 
distinguish genuine line infection from skin contamination during 
removal of the line. 
The ‘sepsis screen’
6
  
Parameter  Abnormal value 
Total leukocyte count <5000/cubic mm 
Absolute neutrophil count Low count as per Manroe chart for 
term infants and Mouzinho chart 
for VLBW babies 
Immature(band cells) to total 
neutrophil ratio 
>0.2 
Micro-ESR >15mm 1st hour 
C-reactive protein (CRP) > 1mg/dl 
Table:2 
A battery of above indirect markers of infection when collectively studied 
provides an extremely reliable index of neonatal sepsis and serves as a 
useful guide for initiating antibiotic therapy. When at least two of the 
indirect markers of infection are positive, it gives the sensitivity and 
specificity of 93 % and 88% respectively. 
The septic screen is indicated at birth if an infant is born following 
prolonged rupture of membranes, foul smelling liquor, peripheral 
maternal fever and severe birth asphyxia with active resuscitation. After 
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birth if baby develops RDS or non specific features of neonatal sepsis, 
septic screen is indicated to support or refute the clinical suspicion so that 
unnecessary antibiotic usage is curtailed during neonatal period. 
Sepsis screen is considered as positive when 2 or more parameters are 
positive. When initial screen is negative, the diagnosis of sepsis can be 
excluded with reasonable certainty. In early onset sepsis, polymorphs in 
the gastric aspirate as a marker of chorioamnionitis can be used as an 
additional parameter of sepsis screen. 
Treatment 
There should be low threshold for starting antibiotic therapy, pending the 
results of culture and other tests. Antibiotics should be given through 
intra venous route, in appropriate dose at appropriate intervals for the age 
and gestation of the baby. The wide range of potential pathogens and the 
propensity of some of the common bacteria to possess or acquire 
antibiotic resistance make the choice of antibiotics difficult.  
The initial choice is guided by three considerations. Knowledge of the 
species of bacteria most likely to cause infection in the particular unit. 
This knowledge is best acquired by the formal collection of data by the 
department of microbiology in the hospital. Knowledge of antibiotic 
resistance pattern of bacteria, most likely to be responsible for the 
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infection, these vary from unit to unit and with in particular unit over 
time, mainly as a result of antibiotic use
37
. Knowledge of patient’s 
previous antibiotic therapy. This is important because previous antibiotic 
therapy predisposes to infection with multi drug resistant organism. 
Initial therapy 
The choice of antibiotic for gram negative bacilli rests between an 
aminoglycoside and a third generation cephalosporin, such as 
ceftazidime, and should be based on local knowledge antibiotic 
resistance, the site of infection and toxicity of particular combinations. If 
Pseudomonas species are suspected ceftazidime should be used in 
preference to cefotaxime. Although a combination of vancomycin and 
either a third generation cephalosporin or an aminoglycoside will cover 
the majority of infections in neonatal unit, a definitive choice can only be 
made if the organism is identified and its susceptibility pattern is 
established. Many newer antibiotics are finding a useful role in difficult 
cases. Aztreonam is valuable in the treatment of gram negative sepsis. 
Meropenem is proving to be a good second line drug. 
Definitive antibiotic therapy 
Once the infecting organism is identified, therapy is rationalized to 
maximize efficacy and to minimize the risk of inducing resistance.  
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The following are suitable antibiotic choices for the common neonatal 
pathogens.  
CONS: Vancomycin is the current drug of choice. The strains of CONS 
responsible for sepsis among babies on a NICU are commonly insensitive 
to penicillin, cloxacillin and gentamycin. Routine susceptibility testing 
sometimes indicates that a CONS resistant to methicillin is sensitive to 
cephalosporins, but cross resistance is common and all CONS that are 
resistant to penicillinase resistant penicillin should be considered resistant 
to cephalosporins. Persistent infection with CONS despite vancomycin 
therapy has been treated successfully with a combination of vancomycin 
and rifampicin
38
. 
Staph aureus: Anti staphylococcal penicillin, such as cloxacillin, should 
be used in preference to vancomycin if the organism is sensitive.  For 
Methicillin resistant staph aureus (MRSA) vancomycin is currently the 
drug of choice although there is evidence of a spectrum of decrease 
vancomycin susceptibility among staphylococcal isolates. Persistent 
infection with MRSA despite vancomycin therapy has been treated 
successfully with a combination of vancomycin and rifampicin. An 
alternative treatment is with the recently introduced antibiotic known as 
linezolid. The usual dose for babies is 10mg/kg twelfth hourly. 
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E.coli: An aminoglycoside or a third generation cephalosporin, depending 
on sensitivity pattern should be used 
Klebsiella: An aminoglycoside or a third generation cephalosporin, 
depending on sensitivity pattern should be used 
Enterobacter, Citrobacter, Serratia and Pseudomonas: An 
aminoglycoside and a third generation cephalosporin in combination 
should be used. Ceftazidime should be used if Pseudomonas is suspected.  
Enterococci: Ampicillin or vancomycin plus an aminoglcoside should be 
used. 
Combination therapy is recommended partly to exploit synergistic 
antibiotic combinations and partly to prevent the emergence of antibiotic 
resistance.  
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Duration of antibiotic sepsis in neonatal sepsis 
Diagnosis  Duration  
Culture and sepsis screen negative 
but clinical picture suggestive of 
sepsis 
5-7 days 
Sepsis screen positive but 
blood/CSF culture negative 
7-10 days 
Blood culture positive but no 
meningitis 
10-14 days 
Meningitis( irrespective of culture 
report) 
21 days 
Arthritis, osteomyelitis, 
endocarditis 
4-6 weeks 
Ventriculitis 6 weeks 
Table: 3 
Meningitis 
The safest initial blind treatment for suspected early-onset meningitis is 
still probably a combination of ampicillin and an aminoglycoside. This 
will effectively begin to treat meningitis caused by GBS, 
L.monocytogenes, Enterococci, H.influenza and many gram negative 
organisms. The alternative choice is a third generation cephalosporin, 
such as cefotaxime or ceftriaxone, plus ampicillin. A combination of third 
generation cephalosporin and an aminoglycoside is sometimes used, but 
this will not effectively treat L.monocytogenes or Enterococci. For late 
onset cases the blind choice is more difficult, but the combination of a 
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third generation cephalosporin and an aminoglycoside probably offers the 
best chance of immediately effective therapy. 
GBS should be treated with benzylpenicillin plus or minus gentamicin 
with which there is some synergy. L.monocytogenes and Enterococci are 
treated with ampicillin and gentamicin. Gram negative bacilli vary so 
much in their sensitivity patterns that definitive therapy can only be 
decided after the microbiology department has carried out sensitivity 
testing. This is especially so in the case of nosocomial infections among 
the inmates of a NICU, who may acquire some very unusual and resistant 
pathogens. Antibiotic therapy for neonatal meningitis should be 
continued intra venous for at least 21days. 
Bone and joint infection 
Vancomycin and a third generation cephalosporin is a reasonable starting 
point until the results of blood cultures are available. Thereafter the 
appropriate antibiotics should be given i.v. for at least 4-6 weeks. When 
pus is obtained at aspiration, orthopaedic advice should always be sought 
about surgical drainage of the bone or joint. 
Urinary tract infection 
The usual antibiotic combinations for either early or late onset sepsis 
should be used and the treatment refined when the results of cultures are 
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available. If UTI is confirmed antibiotics should be continued for 10-14 
days. Resolution of infection should be confirm with further urine 
cultures. Once the infection has been treated, prophylaxis with low dose 
trimethoprim, given in a single dose at night, should continue until 
radiological investigations have excluded underlying abnormalities. If 
the investigations are normal, prophylaxis can be discontinued, but the 
infant should be followed with urinalyses every 3 months for at least a 
year. If there is evidence of reflux antibiotic prophylaxis should be 
continued. UTI due C.albicans has traditionally been treated with 
amphotericin alone or in combination with one of the newer antimycotic 
drugs. A recent report has suggested that results can also be obtained 
with a combination of fluconazole and flucytosine. 
Listeriosis 
The most effective antibiotic therapy is ampicillin plus gentamicin and in 
units where Listeria is a common pathogen; there it is must to be said for 
using this combination as the routine for early onset sepsis. Listeria is 
resistant to all third generation cephlosporins. Intrathecal treatment is not 
required for listerial meningitis.   
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Adjunctive therapies 
Prophylactic use of immunoglobulin: Preterm infants have lower serum 
IgG concentrations than their term counterparts and show a progressive 
fall in IgG concentration for many weeks after birth. Unsupplemented, 
about 15% of VLBW babies will develop IgG concentrations less than 
200mg/dl by about 12 weeks of age
39
. There is evidence that VLBW 
babies who develop hospital-acquired infection have significantly lower 
serum IgG concentrations than those who do not
40
. It was found that if the 
serum IgG was less than 350mg/dl during the first week or less than 
230mg/dl in the second week, the risk of sepsis was five times greater 
than among babies with higher levels. 
It is possible to maintain IgG concentrations in these infants by giving 
regular infusions of immunoglobulin. Numerous studies have looked into 
this, and 19 of them have recently been the subject of an independent 
meta-analysis
41
.The main findings were that the prophylactic use of 
immunoglobulin resulted in a 3% reduction in sepsis and a 4% reduction 
in any serious infection. There was no significant effect on mortality. 
Fresh frozen plasma (FFP): It is commonly used in the treatment of the 
septic infant in an attempt to increase humoral immunity. Adult FFP 
increases neonatal neutrophilic chemotaxis in vitro
42
. When infants were 
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infused with FFP, there was no effect on the serum concentrations of 
components of humoral immunity. 
Exchange transfusion:  It provides humoral factors and removes some 
noxious products of septicemia, like bacterial toxins, fibrin degradation 
products and cytokines. Some studies have suggested that exchange 
transfusion with fresh whole blood is useful in neonatal sepsis
43
. 
Granulocyte transfusion: Granulocytes obtained from plasmapheresis or 
from donor blood have been given to septic babies, particularly when 
their illness has been complicated by neutropenia. The most recently 
published randomized trial has suggested a possible benefit, but overall 
the literature is not convincing. 
Granulocyte colony-stimulating factor and granulocyte-macrophage 
colony-stimulating factor: G-CSF and GM-CSF are crucial in inducing 
granulocyte production and activation in the newborn during sepsis, and 
may be a useful marker of infection. The mononuclear cells of the 
newborn are less able to generate G-CSF than those from adults
44
, and 
this may partly explain granulocytopenia that often accompanies severe 
neonatal sepsis. In human newborns, many trials of recombinant G-CSF 
and GM-CSF in suspected sepsis have proven an increase in neutrophil 
counts and increased functional activity, as judged by C3bi expression. 
There are now many published studies on the influence of G-CSF and 
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GM-CSF on outcome in neonatal sepsis when used either in treatment or 
prophylaxis. An almost universal finding has been a marked rise in the 
neutrophil count, and no acute toxicities have been noted. Evidence of 
efficacy in decreasing mortality rates or other important outcome 
measures is not yet clearly proven and almost all published reports state 
the necessity for bigger and more definitive work. 
Pentoxifylline (oxypentifyline) 
It is an immunomodulating agent which can augment impaired neutrophil 
function in newborn infants. It has a wide range of effects, including 
increasing nitroblue tetrazolium reduction, altering neutrophil 
deformability and increasing H2O2 production
45
. Its use in septic infants 
has not been established. 
Nutrition 
Babies with septicemia are usually catabolic but rarely tolerate enteral 
feeds, because of a paralytic ileus, NEC or gastroenteritis. Intravenous 
feeding, particularly fat is poorly tolerated during septicemia. Due to this 
reason dextrose and electrolytes alone should be used for first 1 to 2 days 
of infection. More complete parenteral or enteral nutrition should be 
given as soon as there is improvement in the baby’s condition. 
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REVIEW OF LITERATURE 
  Alireja Abdollahi et al conducted study on diagnostic value of 
simultaneous measurement of procalcitonin, interleukin-6 and hs-CRP in 
prediction of early onset neonatal sepsis in Vali-e-Asr hospital affiliated 
to Tehram university of medical science, Iran. They conducted study in 
95 neonates who were below 12hours of age and had clinical signs of 
sepsis or maternal risk factor for sepsis. Blood samples were obtained in 
first 12 hours of life and between 24-36 hours of life for determination of 
serum level of PCT, IL-6 and hs CRP. They concluded that the 
combination of PCT and IL-6 yielded sensitivity of 88%, while that of 
PCT and CRP was 82%. Neither combination being significantly higher 
than with PCT alone. Sensitivity of PCT (76%) compared with that of 
CRP (48%) was significantly different (p=0.011). PCT begins to increase 
in 2hours of sepsis onset and precedes the rise IL-6 and CRP
46
. 
          Boo N Y et al conducted study regarding usefulness of a semi 
quantitative procalcitonin test kit for early diagnosis of neonatal sepsis in 
NICU of Hospital University Kebangsaan, kuala Lumpur, Malaysia. 87 
infants were recruited, of which 18 were confirmed to have sepsis based 
on positive blood culture results. They concluded at a  cut off level of 
greater than or equal to 2ng/ml, the sensitivity of PCT Q-kit in detecting 
neonatal sepsis at the onset of signs was 88.9% and its specificity was 
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65.2%. The sensitivity of CRP for diagnosis of sepsis was 55.6% and its 
specificity was 89.9%
47
. 
        Daynia E Bellot et al done study on usefulness of serum 
procalcitonin as an early marker of neonatal sepsis in Neonatal unit, 
Johannesburg hospital, and microbiology laboratory National Health 
Laboratory Service (NHLS), South Africa. They conducted study in 183 
infants admitted to NICU. They concluded PCT predicted 89.5% of 
definitive infection. Receiver Operating characteristic (ROC) curve 
analysis for PCT to predict definitive infection showed odds ratio (OR) 
1.145 (95% confidence interval [CI] 1.05-1.25) with an area under curve 
of 0.778. PCT had a negative predictive value of 0.95 (95% CI 0.915-
0.988) for definitive infection
48
. 
          Claudio chiesa et al conducted study on Reliability of 
Procalcitonin concentration for the diagnosis of sepsis in critically ill 
neonates in The Institute of Experimental Medicine, National Research 
Council and The Institutes of Pediatrics, Child Health and Hygiene, and 
Department of Experimental Medicine, University of Rome, Rome. 
Timed procalcitonin determinations were prospectively obtained during 
two postnatal period 0-48hours of age (period 1) and 3-30 days of age 
(period 2). In period 1 PCT level was measured in 83 healthy newborn 
and in 120 NICU patients. Analysis of pooled procalcitonin values 
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obtained for group1 patients over the 48hours period after birth yielded 
sensitivity of 92.6% and specificity 97.5%. In period 2, blood samples 
from 23 cases with systemic infections were analyzed for procalcitonin 
concentration at the onset of signs of infection showed sensitivity and 
specificity 100%
49
. 
            Claudio chiesa et al conducted study on C - reactive protein, 
Interleukin-6 and procalcitonin level in the immediate postnatal period 
and the influence of illness severity, risk status, antenatal and perinatal 
complication and infection on it. The Score for Neonatal Acute 
Physiology (SNAP) was used to define illness severity, with SNAP 
Perinatal Extension (SNAP-PE) used to define the combined 
physiological and perinatal mortality risk. A total of 134 ill neonates were 
analyzed for the association of SNAP, SNAP-PE and maternal and 
perinatal variables with C-reactive protein (CRP), interleukin-6 (IL-6) 
and procalcitonin (PCT) concentration at birth, 24 and 48 hours of life. 
They concluded that early onset neonatal infection was associated with 
significant increase in CRP, IL-6 and PCT concentration at all three 
points independent of illness severity. However in babies without 
infection, higher SNAP and SNAP_PE score were associated with higher 
IL-6 concentration at birth. PCT sensitivity and specificity was greater 
than that of CRP and IL-6
50
. 
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             N joram et al conducted study on Umbilical cord blood 
procalcitonin and C-reactive protein concentrations as markers for early 
diagnosis of very early onset neonatal infection. Procalcitonin (PCT) and 
C-reactive protein (CRP) concentrations in umbilical cord blood of 197 
neonates were measured to evaluate their value as markers of infection. 
Sixteen of the neonates were infected. The sensitivity, specificity, and 
negative and positive predictive values were respectively 87.5%, 98.7%, 
87.5%, and 98.7% for PCT and 50%, 97%, 67%, and 94% for CRP. 
Serum PCT in cord blood seems to be a useful and early marker of 
antenatal infection
51
. 
            Ibeh Isaiah Nnanna et al had done a study on usefulness of 
serum procalcitonin as an early detection of neonatal bacteraemia and 
septicaemia in a tertiary health care facility. They conducted study in 60 
neonates suspected to have sepsis. A total of 55 neonates showed a 
positive PCT test. An important finding was that PCT on day 0 was the 
only independent risk factor associated with previous infection, odds 
ratio= 7.69, 95% CI: 2.50- 25: p< 0.001. The diagnostic value of PCT 
evaluated through construction of corresponding ROC curves was 0.89 
(95% CI, 0.79- 0.98) and positive and negative value reached 91.6% and 
80% respectively. When compared with body temperature, leucocyte 
count and CRP, PCT was the most accurate marker for infection
52
. 
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               Yadolla Zahedpasha et al conducted study on Procalcitonin as 
a Marker of Neonatal Sepsis in  Department of Pediatrics, Babol 
University of Medical Sciences, Babol, IR Iran. Thirty‐eight neonates 
with clinical (n=8), suspected (n=19) and proven sepsis (n=11) were 
evaluated. The PCT levels were measured by immuno luminoassay 
before and on day 5 of treatment. PTC levels of 0.5‐2 ng/ml, 2.1‐10 ng/ml 
and >10 ng/ml were considered as weakly positive, positive, and strongly 
positive respectively. The result showed that the serum procalcitonin 
levels seem to be significantly increased in proven sepsis and decrease 
dramatically in all types of sepsis after appropriate treatment53. 
          Vincenzo Maniaci, MD et al conducted study on Procalcitonin in 
Young Febrile Infants for the Detection of Serious Bacterial Infections in 
Division of Emergency Medicine and Department of Medicine, 
Children’s Hospital Boston. A total of 874 patients, ≤90 days of age, with 
documented temperatures of ≥38 degree Celsius were evaluated during 
the 18-month study period.  ROC curves for procalcitonin level were 
constructed by comparing patients with definite serious bacterial 
infections (SBIs) and those with no serious bacterial infection (no SBI). 
In comparing definite SBIs and no SBI, the ROC area under the curve 
(AUC) was 0.82; a cut off value of 0.13 ng/mL yielded sensitivity of 
96.7% (95% CI: 81.0%–99.8%), specificity of 30.3% (95% CI: 24.0%–
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37.5%), NPV of 98.3% (95% CI: 89.7% –99.9%), and negative likelihood 
ratio of 0.11  (95% CI: 0.02–0.76)
54
.  
            Procalcitonin in preterm infants during the first few days of life: 
Introducing an age related normogram conducted by D Turner et al in 
neonatal intensive care unit at Shaare Zedek Medical Center, a University 
affiliated hospital in Jerusalem, Israel. The suggested neonatal 
normograms of preterm infants are different from those of term infants. 
Procalcitonin concentrations exceeding the 95th centile may be helpful in 
detecting congenital infection, but not at birth
55
.    
           An update on the use of C-Reactive Protein in early-onset neonatal 
sepsis: Current insights and new tasks by  Nora Hofer
 
 et al at Research 
Unit for Neonatal Infectious Diseases and Epidemiology, Medical 
University of Graz.  The delayed induction of the hepatic synthesis of 
CRP during the inflammatory response to infection lowers its sensitivity 
during the early phases of sepsis. The performance of serial 
determinations 24–48 hrs after the onset of symptoms is recommended; 
as it clearly improves diagnostic accuracy.CRP is particularly useful for 
monitoring the response to treatment and for ruling out an infection. A 
repeated determination of CRP 24–48 hrs after the initiation of antibiotic 
therapy has been reported to carry a 99% negative predictive value in 
accurately identifying uninfected neonates, though nothing replaces a 
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clinical impression and the gold standard. CRP values undergo a 
physiological 3-day rise after birth. This physiologic dynamics as well as 
certain maternal and perinatal factors may affect interpretation of what 
constitutes ‘normal’ CRP values in healthy neonates. Furthermore, some 
reports suggest noninfectious confounders such as meconium aspiration 
syndrome and perinatal maternal risk conditions may significantly elevate 
CRP values in symptomatic or at-risk neonates and thus confound 
interpretation of CRP values in the diagnosis of sepsis56. 
           Bacteriological Analysis of Blood Culture Isolates from Neonates 
in a Tertiary care hospital in India done by Ghanshyam D et al in 
Department of Pediatrics and Department of Microbiology, University 
College of medical Sciences and GTB Hospital, New Delhi.  In total, 823 
blood cultures from neonates were evaluated. Gram-positive cocci 
(309/823, 37.5%), Gram-negative bacilli (492/823, 59.8%), and Candida 
species (20/823, 2.43%) were grown. Staphylococci and Klebsiellae were 
the most common Gram-positive and Gram-negative organisms together 
accounting for 32.3% (266/823) and 33.8% (278/823) of the isolates 
respectively. Other common Gram-negative isolates were Enterobacter 
(62/823, 7.5%) and Escherichia coli (38/823, 4.6%)
57
.  
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             Kurien Anil Kuruvilla et al from the Department of 
Neonatology and Microbiology, Christian Medical College 
Hospital, Vellore, Tamil Nadu, India conducted study on bacteriological 
profile in sepsis in neonates in South India. They concluded that the 
incidence of neonatal bacterial sepsis is 9.8 per 1000 live births. E. coli-
and Klebsiella were the most common organisms causing EOS and LOS, 
respectively. Enterococcus fecalis was also a major pathogen, both in 
EOS and LOS58.  
 
               The effect of neonatal sepsis on platelet count and their indices 
conducted by Abdalla Alshorman et al in Princess Rahmah Teaching 
Hospital, Irbid, Jordan.    Neonatal sepsis was diagnosed in 105 cases was 
included in the study. Thrombocytopenia was present in 45(42.8%) of the 
all cases of neonatal sepsis, of which 27 (60%) were found among gram 
negative sepsis. The remaining 18(40%) cases were due to gram-positive 
microorganisms. 19 (42.2%) of the cases of thrombocytopenia are 
premature babies and 26(57.8%) are full term babies
59
.  
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JUSTIFICATION OF THE STUDY 
 
Neonatal sepsis is the most important cause of neonatal mortality & 
morbidity, especially among low birth weight and preterm babies. Early 
recognition, diagnosis and treatment of serious infections in the neonates 
are essential. Progression from mild symptoms to death can occur in less 
than 24hrs. Most neonatal bacterial infections have an early bacteraemia 
phase preceding the development of a full blown septicemia or 
localization of infections in organs and tissues. During this phase the 
clinical signs are subtle, but this is when treatment must be started if there 
is to be intact survival. Early detection of neonatal systemic infection is 
difficult because the symptoms and signs of bacterial infection are 
nonspecific and similar to symptoms of non infectious process like 
respiratory distress syndrome and IEM. Though the blood culture is the 
gold standard test for sepsis, it takes longer time to get the results. The 
sensitivity of blood culture is less and is influenced by antibiotic use. 
Hence we need markers which can be performed as a screening procedure 
to predict sepsis at the earliest. In our setup we use WBC count and CRP 
value for early detection of sepsis. Interpretation of WBC count is 
difficult because of wide range of normal value in infants (5000 – 20000). 
CRP is a nonspecific inflammation and tissue necrosis. It is also elevated 
in noninfectious causes like respiratory distress syndrome and meconium 
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aspiration syndrome. CRP level do not rise significantly until 24 – 48 hrs 
of illness leading to false interpretation when sample is drawn early in the 
course of illness. 
Recently procalcitonin (PCT) has been found to be useful marker in early 
diagnosis of bacterial infection. Bacterial lipopolysaccharide has been a 
potent inducer of PCT release in to systemic circulation. PCT level starts 
to rise from 3 - 4 hrs after an endotoxin challenge and peaks about 6 hrs.  
PCT has half life of 25 to 30 hrs. If we are able to measure PCT at the 
onset of infection we can initiate specific treatment without waiting for 
Culture results. In this study we aimed to find out the sensitivity of PCT 
as an early marker of neonatal sepsis and to compare CRP, WBC count 
and platelets with PCT in early detection of neonatal sepsis. 
 
 
 
 
 
 
 
 
 
 
59 
 
                                             OBJECTIVES 
Primary objective: 
       Procalcitonin as an early and reliable marker of neonatal sepsis 
Secondary objective: 
      To compare the effectiveness of CRP and WBC with procalcitonin in 
predicting the neonatal sepsis at the earliest  
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METHODOLOGY 
Study design:   Validation of diagnostic test 
Study place:   NICU, Coimbatore medical college and hospital (CMCH). 
Study period: Dec 2011 to Sep 2012  
Study population: All neonates admitted in NICU, in CMCH with risk 
of sepsis or suspected sepsis either at admission or during the course of 
admission during the study period 
Inclusion criteria: 
 Neonates  with risk of early onset sepsis 
1. PROM > 18 hours 
2. MRO > 12 hours 
3. Maternal fever during perinatal period 
4. Foul smelling liquor 
 Neonates admitted with Signs and symptoms S/O sepsis both EOS 
and LOS  
1. Feeding intolerance 
2. Lethargy 
3. Temperature instability 
4. Apnea  and respiratory distress 
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5. Poor perfusion 
6. Seizure 
7. Tachycardia 
8. Abdominal distension 
Exclusion criteria: 
 Newborn already started on antibiotics 
Sample size: 49 
Sample size estimation formula - Y = µ1-µ2/ σ                                                                                                                     
               Y - The difference between the two population means  
     σ - Population standard deviation  
    Based on Previous studies   µ1= 5.49  
                                             µ2= 5.21  
                                             SD or σ = 0 .56  
                                                       Y    = 0.50  
 Corresponding to Power at 0.50 at ά 0.70, the estimated sample 
size is 49.  
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Sampling technique: All consecutive neonates fulfilling inclusion 
criteria were studied until the sample size was achieved.  
DEFINITIONS 
Culture positive sepsis: Neonates whose blood culture showed growth 
of the organisms. 
Culture negative sepsis: Neonates whose blood culture showed no 
growth of the organisms, but had other positive investigations suggesting 
sepsis. 
Early onset sepsis: Neonates who developed features of sepsis within 
72hrs of life.  
Late onset sepsis: Neonates who developed features of sepsis after 72hrs 
of life.  
Normal values: Procalcitonin - <0.05ng/dl 
                          CRP – 0.5mg/dl 
                          WBC – 5000 – 20000/cumm 
                          Platelet count – 1-5lakhs/cumm 
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2×2 Table
60 
 
       Screening 
test 
                        Diagnostic test  
              Total              Positive              
Negative 
      Positive           a           b       a+b 
      Negative           c          d      c+d 
       Total         a+c        b+d   a+b+c+d 
Table:4 
• Sensitivity: probability that a test result will be positive when the 
disease is present (true positive rate). It is calculated by the formula 
a /a+c × 100. 
• Specificity: probability that a test result will be negative when the 
disease is not present (true negative rate). It is calculated by the 
formula d /b+d × 100. 
• Positive likelihood ratio: ratio between the probability of a 
positive test result given the presence of the disease and the 
probability of a positive test result given the absence of the disease, 
i.e. True positive rate / False positive rate = Sensitivity /               
(1-Specificity)  
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• Negative likelihood ratio: ratio between the probability of a 
negative test result given the presence of the disease and the 
probability of a negative test result given the absence of the 
disease, i.e.  False negative rate / True negative rate =                       
(1-Sensitivity) / Specificity  
• Positive predictive value: probability that the disease is present 
when the test is positive. It is calculated by the formula                    
a /a+b × 100. 
• Negative predictive value: probability that the disease is not 
present when the test is negative. It is calculated by the             
formula d /c+d × 100. 
Maneuver  
50 newborns fulfilling inclusion criteria were enrolled. Consent was 
obtained from the parents. Relevant data including risk factors, clinical 
condition, were entered in preformed proforma. Before initiation of 
antibiotic therapy, blood sample for blood culture, CRP, PCT and WBC 
were obtained from peripheral vene puncture. Results will be interpreted 
and compared as follows: Culture positivity was taken as gold standard. 
PCT, CRP and WBC sensitivity, specificity, positive predictive value and 
negative predictive values were calculated by 2×2 table. Efficacy CRP 
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and WBC levels were compared with that of PCT in predicting neonatal 
sepsis. 
Analysis was done using software MedCalc software – version 15. 
Methods 
CBC: Calculated by autoanalyser 
Blood culture: 0.5ml of blood was collected in a container containing 
5ml of Brain Heart Infusion Broth. It was incubated over 48 hours at 35-
37 degree Celsius and plated on Mc Conkey agar and blood agar. Growth 
was checked after 24 hours. 
CRP assay: Done in Immuno lab at Coimbatore by Immunoturbidimetric 
method. In this the serum sample is reacted with the buffer and anti-CRP 
coated latex. The formation of antibody-antigen complex during the 
reaction results in increase in turbidity. The extent of turbidity was 
measured as the amount of light absorbed at 570nm. By constructing a 
standard curve from the absorbance standards, CRP concentration of the 
sample was determined. Value ≥ 1mg/dl was taken as positive as per lab 
standard. 
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Procalcitonin assay: It was done at Immuno lab at Coimbatore by 
enzyme linked fluorescent assay (ELFA). The assay principle consists of 
one strip immune assay sandwich procedure with a final fluorescent 
detection. The solid phase receptacle (SPR) acts as a solid phase, as well 
as the pippeting device for the assay. Materials for the assay are ready to 
use and pre dispensed in the sealed reagent strips. All of the assay steps 
were done automatically by the instruments. The serum sample was put in 
the wells containing anti-procalcitonin antibodies coated with alkaline 
phosphatase (conjugate). The mixture of the sample and conjugate was 
passed in and out of the SPR several times. This procedure enables the 
antigen to combine with the immunoglobulin fixed to the interior wall of 
SPR and the conjugate to make a sandwich. Unbound substances were 
eliminated during washing. 
          Two detection procedures were performed successfully. During 
each step, the substrate (4-methyl-umbelliferyl phosphate) was passed in 
and out of SPR. The conjugate enzyme catalyses the hydrolysis of 
substrate into a fluorescent product, (4-methyl-umbelliferone). The 
fluorescence of which was measured at 450nm. The intensity of the 
fluorescence is proportional to the concentration of antigen present in the 
sample. 
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            At the end of the assay, the results were automatically calculated 
by the instrument in relation to the two calibration curves corresponding 
to two procedures and saved in memory, and then printed out. Value ≥ 
2ng/dl was taken as positive as per lab standard. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
RESULTS 
 A total of 50 neonates with features of sepsis were included in the study. 
Blood culture of 27 (54%) neonates showed growth of organism. Out of 
remaining 23(46%) neonates, 15(30%) had other positive investigations 
supportive of sepsis and termed as culture negative sepsis group. Rest of 
8(16%) neonates had only clinical features of sepsis and no other 
supportive investigation for sepsis and termed as suspected sepsis. 
The data obtained were analyzed as follows: 
1. Features of study population ( gestational age, birth weight, 
postnatal age, sex ) 
2. Percentage of early onset and late onset sepsis in study population 
3. Organisms causing neonatal sepsis and its frequency. 
4. Sensitivity, specificity, positive and negative predictive value, 
positive and negative likelihood ratio for procalcitonin, CRP, WBC 
count and platelet count. 
5. Sensitivity, specificity, positive and negative predictive value, 
positive and negative likelihood ratio for combination of tests 
included in the study. 
6. Receiver operated characteristic (ROC) curve for comparing the 
efficacy of PCT, CRP and WBC count. 
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7. Association between sampling interval with PCT & CRP level by 
partial correlation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GESTATIONAL AGE DISTRIBUTION (WEEKS)
Figure 1: distribution 
 Figure 2: distribution of gestational age in study population among three 
groups 
Out of 50 neonates included in the study, 39 (78%) were term, 3 (6%) 
were between 32-34 wks, 2(4%) were between 28
between 30-32wk 
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Figure 3: distribution of sex in study population
Figure 4: distribution of sex in study population among three groups
 
Out 50 neonates in the study 26 (52%) were male and 24 (48%) were 
female infants 
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 Figure 5: distribution of weight in study population
Figure 6: distribution of weight in study population among three groups
Out of 50 neonates 21(42%) weighed between 2
weighed between 1-1.9kg, 
weighed > 4kg and 2 weighed < 1kg
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Figure 7: distribution of age in study population 
Figure 8: distribution of a
Out of 50 neonates 27 (54%) were above 72 hours and 23 (46%) were 
below 72 hours 
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Figure 9: distribution of LOS & EOS in study population among three 
groups 
 
Figure 10: frequency 
Out of 27 positive blood culture ,  Klebsiella pneumonia
in 17(62.9%),  Coagulase negative staphylococcus was identified in 4 
cases (14.8%), Enterobacter spp was identified in 3 cases (11.1%), 
Pseudomonas was identified in 2 cases (7.4%) and Enterococcus was 
identified in 1 case (3.7%)
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                                 STATISTICAL ANALYSIS 
Table: 5     
PCT 
Blood culture 
Total 
Positive Negative 
Positive 25 10 35 
Negative 2 13 15 
Total 27 23 50 
 
Sensitivity - 92.59% 
Specificity - 56.52 % 
Positive Predictive Value - 71.4 % 
Negative Predictive Value - 86.6% 
Positive Likelihood Ratio - 2.13  
Negative Likelihood Ratio – 0.13 
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Table: 6     
CRP 
Blood culture 
Total 
Positive Negative 
Positive 15 10 25 
Negative 12 13 25 
Total 27 23 50 
 
Sensitivity – 55.55% 
Specificity – 56.52 % 
Positive Predictive Value – 60 % 
Negative Predictive Value – 52 % 
Positive Likelihood Ratio – 1.28        
Negative Likelihood Ratio – 0.79 
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Table:7 
WBC 
Culture 
Total 
Positive Negative 
Positive 11 11 22 
Negative 16 12 28 
Total 27 23 50 
 
 
Sensitivity – 40.74% 
Specificity – 52.17 % 
Positive Predictive Value – 50 % 
Negative Predictive Value – 42.85 % 
Positive Likelihood Ratio – 0.85         
Negative Likelihood Ratio – 1.14 
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Table:8 
Platelet 
 
Culture 
Total 
Positive Negative 
Positive 10 3 13 
Negative 17 20 37 
Total 27 23 50 
 
 
Sensitivity – 37.03% 
Specificity – 86.95 % 
Positive Predictive Value – 76.92 % 
Negative Predictive Value – 54.05 % 
Positive Likelihood Ratio – 2.84       
Negative Likelihood Ratio – 0.72 
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Table:9      
CRP/WBC 
Culture 
Total 
Positive Negative 
Positive 21 13 34 
Negative 6 10 16 
Total 27 23 50 
 
Sensitivity – 77.77% 
Specificity – 43.47% 
Positive Predictive Value – 61.76 % 
Negative Predictive Value – 62.5% 
 
Table:10     
CRP /WBC/Platelets                         Culture Total 
Positive Negative 
Positive 22 14 36 
Negative 5 9 14 
Total 27 23 50 
       
Sensitivity – 81.48% 
Specificity – 39.13% 
Positive Predictive Value – 61.11 % 
Negative Predictive Value – 64.29% 
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Table:11      
Procalcitonin/ CRP                         Culture Total 
Positive Negative 
Positive 27 15 42 
Negative 0 8 8 
Total 27 23 50 
 
Sensitivity – 100% 
Specificity – 34.78% 
Positive Predictive Value – 64.28% 
Negative Predictive Value – 100% 
 
 
Table:12      
Procalcitonin/ WBC                         Culture Total 
Positive Negative 
Positive 25 15 40 
Negative 2 8 10 
Total 27 23 50 
       
Sensitivity – 92.59% 
Specificity – 34.78% 
Positive Predictive Value – 62.5% 
Negative Predictive Value – 80% 
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Table:13      
Procalcitonin/ 
Platelets 
                        Culture Total 
Positive Negative 
Positive 26 1 27 
Negative 1 22 23 
Total 27 23 50 
       
Sensitivity – 96.29% 
Specificity – 95.65% 
Positive Predictive Value – 96.29% 
Negative Predictive Value – 95.65% 
 
 
Table:14      
Procalcitonin/ 
WBC/CRP/Platelets 
                     Culture Total 
Positive Negative 
Positive 27 17 44 
Negative 0 6 6 
Total 27 23 50 
       
 
Sensitivity – 100% 
Specificity – 26.08% 
Positive Predictive Value – 61.36% 
Negative Predictive Value – 100% 
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COMPARISION OF PCT, CRP & WBC 
 
Figure 11: Comparison of PCT,CRP and WBC count by ROC curve 
Table:15 
Comparison of ROC curves 
Variable 1 CRP 
Variable 2 procalcitonin 
Variable 3 WBC COUNT 
 
Classification 
variable 
culture 
Sample size 50 
Positive group :  culture = 1 27 
Negative group :  culture = 0 23 
 AUC SE  95% CI  
CRP 0.552 0.0831 0.405 to 0.693 
procalcitonin 0.748 0.0729 0.605 to 0.860 
WBC_COUNT 0.539 0.0840 0.392 to 0.681 
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Table:16 
Pair wise comparison of ROC curves 
 
CRP ~ procalcitonin 
Difference between 
areas  
0.196 
Standard Error 0.107 
95% Confidence Interval -0.0134 to 0.405  
z statistic 1.834 
Significance level P = 0.0466 
CRP ~ WBC_COUNT 
Difference between 
areas  
0.0137 
Standard Error 0.131 
95% Confidence Interval -0.244 to 0.271  
z statistic 0.104 
Significance level P = 0.9169 
Procalcitonin ~ WBC_COUNT 
Difference between 
areas  
0.209 
Standard Error
c
 0.124 
95% Confidence Interval -0.0338 to 0.453  
z statistic 1.687 
Significance level P = 0.0315 
 
The difference between area under ROC curve for PCT and CRP was 
0.196 and p=0.0466 (p<0.05) which means there is significant difference 
between the efficacy of PCT & CRP in predicting neonatal sepsis. 
The difference between area under ROC curve for PCT and WBC was 
0.209 and p=0.0315 (p<0.05) which means there is significant difference 
between the efficacy of PCT & WBC in predicting neonatal sepsis. 
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C-REACTIVE 
PROTEIN 
 
Figure 11: Scatter diagram between sampling interval and CRP level 
Table:17  
Partial correlation 
Covariates sampling duration 
Sample size 50 
Correlation coefficient r 0.8641 
Significance level P=0.0067 
 
Sampling interval has excellent correlation with CRP level, Pearson’s 
correlation r=0.86 and p<0.05.  Increased Sampling interval was 
associated with increased positivity for CRP.  
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Figure 12: Scatter diagram between sampling interval and procalcitonin 
level 
Table:18 
Partial correlation 
Variable Y Procalcitonin 
Variable X Culture 
Covariates sampling duration 
Sample size 50 
Correlation coefficient r 0.5167 
Significance level P=0.0801 
 
Sampling interval had no significant correlation with PCT level, 
Pearson’s correlation r=0.516 and p>0.05.   
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DISCUSSION 
 
The major cause of neonatal morbidity and mortality is neonatal sepsis. 
This study was conducted to show Procalcitonin can be used as an early 
and reliable marker of neonatal sepsis and to compare its efficacy with 
that of CRP and WBC count. These two tests are routinely used in our 
institution for initial sepsis screening. If CRP and WBC count are as 
efficacious as procalcitonin, they can be substituted for procalcitonin in 
resource poor setting and cost effective. 
This study was conducted in 50 neonates who had clinical features of 
sepsis. Both preterm and term neonates were included. Both early onset 
sepsis and late onset sepsis were included. Blood samples were drawn for 
CRP, PCT, WBC count and blood culture before starting antibiotics. 
Other investigations like CSF analysis, CXR were done in symptomatic 
infants. 
Out of 50 neonates blood culture was positive in 27 (54%) neonates.15 
out of remaining 23 infants had other positive investigations like CSF 
analysis, CXR supporting sepsis and hence grouped as culture negative 
sepsis. Remaining 8 neonates had only clinical features and hence termed 
as suspected sepsis. Procalcitonin was positive (≥2ng/dl) in 35 neonates, 
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CRP was positive (≥1mg/dl) in 25 neonates and WBC count was positive 
(<5000 or > 20,000) in 22 neonates. 
Sensitivity, specificity, positive predictive value and negative predictive 
value are calculated for PCT, CRP and WBC count taking blood culture 
as gold standard test. The sensitivity, specificity, positive predictive value 
and negative predictive value for procalcitonin were 92.59%, 56.52%, 
71.4% and 86.6% respectively. The sensitivity, specificity, positive 
predictive value and negative predictive value for CRP were 55.55%, 
56.52%, 60% and 52% respectively. The Sensitivity, specificity, positive 
predictive value and negative predictive value for WBC count were 
40.74%, 52.17%, 50% and 42.85%. 
Procalcitonin had highest sensitivity (92.59%) compared to that of CRP 
(55.55%) and WBC count (40.74%). The specificity of procalcitonin 
(56.52%) was almost same as that of CRP, but greater than the specificity 
of   WBC count (52.17%) and lesser than that of platelet count (86.95%). 
The positive predictive value (71.4%) and negative predictive value 
(86.6%) of procalcitonin were higher than positive and negative 
predictive value of CRP and WBC count, which were (60%, 52%) and 
(50% and 42.85%) respectively. 
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When comparing procalcitonin with combine effectiveness of CRP, WBC 
count and platelet count, PCT had higher sensitivity (92.59%) and 
specificity(56.52%) than combined CRP,WBC and Platelet, which were 
81.48% and 39.13%.  
Platelet count was reduced (<1 lakh) in 13 neonates out of 50 neonates. 
The sensitivity, specificity, positive predictive value and negative 
predictive value of platelet count were 37.03%, 86.95%, 76.92% and 
54.05% respectively. Platelet count had high specificity (86.95%) 
compared to other tests.  
Combination of PCT and CRP had 100% sensitivity but at the cost of 
specificity (34.78%), where as the combination of PCT and platelet had 
both high sensitivity and specificity which were 96.29% and 95.65% 
respectively. 
Comparison of efficacy of procalcitonin, CRP and WBC count by ROC 
curve analysis showed significant difference between the efficacy of 
procalcitonin and CRP  with p value of 0.046 (<0.05), and between 
procalcitonin and WBC count with p value of 0.0315. The difference 
between the efficacy of CRP and WBC count was not significant p= 
0.916 (p> 0.05).  
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When both culture positive and culture negative sepsis group were 
included in the analysis, the specificity of procalcitonin (87.5%), CRP 
(75%) and WBC count (62.5%) were increased. 
The association between sample interval ( duration between onset of 
symptoms and blood sampling) with CRP and PCT levels by partial 
correlation showed there was strong association between sampling 
interval and CRP level, with Pearson’s correlation r=0.86 and p <0.05. 
Sampling interval more than 10 hours was associated with increased 
positivity of CRP. Whereas the correlation between sampling interval and 
procalcitonin was not significant p>0.05. Procalcitonin was positive at 
short sampling interval as earlier as 1 hour. 
In our study procalcitonin value of ≥ 2ng/dl has sensitivity & specificity 
of 92.59% and 56.52%. This is similar to the study conducted by Boo N 
Y et al
47
 on procalcitonin which showed sensitivity of 88.9% and 
specificity of 65.2%. 
The positive predictive value and negative predictive value of 
procalcitonin in our study was 71.4% and 86.6% respectively. Similar 
study conducted by Ibeh Isaiah et al
52
 had showed procalcitonin with 
positive predictive value and negative predictive value 92.6% and 80% 
respectively. 
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In our study CRP level ≥ 1mg/dl has sensitivity 55.55% and specificity 
56.52%. This is comparable to the study conducted by Boo N Y et al
47
 
which showed sensitivity and specificity of CRP were 55.6% and 89.9% 
respectively. 
The sensitivity, specificity, positive predictive value and negative 
predictive value of WBC count (<5000 or > 20,000) in predicting 
neonatal sepsis were 40.74%, 52.17%, 50% and 42.85% respectively. 
Similar study conducted by Mohammad Ibrahim Aboud et al60 showed 
the sensitivity, specificity, positive predictive value and negative 
predictive value of WBC count were 72%, 63%, 66% and 69% 
respectively ,while that of CRP (> 2mg/dl)  were 80%, 77%, 77% and 
90% respectively and that of procalcitonin (> 0.8ng/dl)  were 84%, 86%, 
86% and 84% respectively. 
In this study out of 27 positive blood culture, 17 (62.9%) were positive 
for Klebsiella pneumonia followed by Coagulase negative staphylococcus 
which was positive in 4 cases (14.8%). This was comparable to the study 
conducted by Kurien Anil Kuruvilla et al
58
 in Tamilnadu, where they 
showed most common organism causing early onset sepsis was E.coli and 
late onset sepsis was Klebsiella pneumoniae. 
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In our study out of 27 culture positive cases thrombocytopenia was 
present in 13 cases (48%) which was comparable to the study conducted 
by Abdallah Alshorman et al
59
. The study showed thrombocytopenia 
was present in 42.8% of culture positive sepsis. 
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                                                  SUMMARY 
1. Number of cases studied : 50 
2. Male =26 and female = 24 
3. Age : >72 hrs -27, < 72hrs -23 
4. Gestational age distribution 
Table:19 
     ≥ 37 weeks           34 
   34-36 weeks            5 
   32-34 weeks            3    
   30-32 weeks           1 
   28-30weeks           2 
             
5. Weight distribution 
      Table:20 
 
 
 
 
 
6.  Number of culture positive cases : 27 
    < 1 kg           2 
1- 1.9 kg           14 
2- 2.9 kg          21 
3- 3.9 kg          11 
 >4kg          2 
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     7. Number of early onset sepsis among culture positive :14 
8. Number of late onset sepsis among culture positive : 13 
9. Frequency of organisms 
                                                                                                                                                                                      
Table:21 
 
 
 
 
 
10.  Number of  procalcitonin positive cases :35 
11.  Number of  CRP positive cases :25 
12.  Number of  WBC count positive cases : 22 
13. Culture positive was taken as gold standard and diagnostic 
efficacy was calculated using 2×2 stastistic table 
 
 
 
 
Klebsiella pneumoniae 17 
Coagulase negative staphylococcus 4 
Enterobacter spp 3 
Pseudomonas aeruginosa 2 
Enterococcus  1 
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Table:22 
 Tests  Sensitivity Specificity PPV NPV 
Procalcitonin 92.59% 56.52% 71.4% 86.6% 
CRP 55.55% 56.52% 60% 52% 
WBC count 40.74% 52.17% 50% 42.85% 
PLT 37.03% 86.95% 76.92% 54.05% 
PCT/CRP 100% 34.78% 64.28% 100% 
PCT/WBC 92.59% 34.78% 62.5% 80% 
PCT/PLT 96.29% 95.65% 96.29% 96.25% 
PCT/CRP/WBC/PLT 100% 26.08% 61.36% 100% 
CRP/WBC 77.77% 43.37% 61.76% 62.5% 
CRP/WBC/PLT 81.48% 39.13% 61.11% 64.29% 
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CONCLUSION 
 Procalcitonin can be used as an early and reliable marker of 
neonatal sepsis. 
 CRP and WBC count though can be used as initial sepsis 
screening; it cannot be substituted for procalcitonin. 
 No combined investigation excluding procalcitonin was superior to 
procalcitonin. 
 Combination of procalcitonin and CRP had highest sensitivity but 
low specificity. 
 Combination of procalcitonin and platelet had both higher 
sensitivity and specificity. 
 Sampling interval greatly influence the level of CRP but not 
procalcitonin level. 
 Klebsiella Pneumoniae is the most common organism causing both 
early onset and late onset sepsis in our institution. 
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                                    CONSENT FORM 
Your child ……………………………..  is being asked to be a participant in the research 
study titled “PROCALCITONIN AS AN EARLY AND RELIABLE MARKER OF 
NEONATAL SEPSIS””  in CMC Hospital, Coimbatore, conducted by Dr.J.Fouziya parveen ,  
Post Graduate Student, Department of Paediatrics, Coimbatore Medical College. Your child is 
eligible after looking into the inclusion criteria. You can ask any question you may have 
before agreeing to participate. 
RESEARCH BEING DONE 
To show procalcitonin is an early and reliable marker of  neonatal sepsis  
PURPOSE OF RESEARCH 
To diagnose neonatal sepsis at the earliest  and there by provide early intervention  
PROCEDURE   
3.5 ml of blood is drawn from infants with features suggestive of sepsis for procalcitonin, 
CRP,WBC count and blood culture.  
Decline from Participation 
You have the option to decline from participation in the study existing protocol for your 
condition. 
Privacy and Confidentiality 
Privacy of individuals will be respected and any information about your child or provided by 
you during the study will be kept strictly confidential. 
Authorization to publish Results   
Results of the study may be published for scientific purposes and/or presented to scientific 
groups; however your child will not be identified. 
Statement of Consent 
I volunteer and consent  my child  to participate in this study. I have read the consent or it has 
been read to me. The study has been fully explained to me, and I may ask questions at any 
time. 
 
-------------------------------                                                    -------------------------------   
Signature /Left thumb impression of parent                       Date 
 
107 
 
PROFORMA 
New born                                             
• Name 
     
• Age                                                             
• Sex                                                     
• Date of birth & time of birth  
• Mode of delivery       
• LSCS indication                           
• APGAR                                              
• Birth wt         
                                                                                                 
                                                             
MOTHER 
• Name 
• Age 
• Parity 
• LMP/EDD 
• Blood grouping & typing  
• Duration of 2nd stage of labour  
• H/O perinatal fever, foul smelling liquor 
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H/O bad CRP 
 H/OFeeding intolerance 
        Lethargy 
        respiratory distress 
        Seizure 
        Abdominal distension 
        jaundice 
Examination 
• Cry  & activity : 
• Colour  
• Temperature 
• Tone 
• HR 
• RR 
• SPO2 
• CVS 
• RS 
• ABDOMEN 
• CNS  
109 
 
                                           
TIME GAP BETWEEN SYMPTOMS & SAMPLING: 
LAB DATA 
• WBC 
• PCT 
• CRP 
• Other  positive lab findings  
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MASTER CHART 
 
S.NO 
 
NAME 
 
GEST 
AGE 
WEEKS 
 
AGE 
HRS 
 
SEX 
 
WT 
KG 
 
SYMPTOMS 
 
SAMP 
INTVL 
HRS 
 
PCT 
NG/DL 
 
CRP 
MG/DL 
 
WBC 
/CUMM 
 
PLT 
L/CUMM 
 
CXR 
 
CSF 
 
OTHERS 
 
BLOOD 
CULTURE 
 
CELLS/DL 
 
PROTEIN 
MG/DL 
1 B/O NAGAJOTHI ≥ 37 96 F 3 LETHARGY,ROF 12 28.91 7.9 3200 0.17 - - - - K. PNEUMONEA 
2 B/O SEVI ≥37 96 M 1.8 LETHARGY,ROF 10 200 10.8 31000 0.15 - - - - K. PNEUMONEA 
3 B/O VICTORIA 30-32 14 F 0.9 PPROM >96HRS 14 10.9 0.3 2500 1.8 - - - - K. PNEUMONEA 
4 B/O DEVI ≥37 96 M 2.1 SEIZURE 8 7.3 0.2 15000 2.6 - 60 260 - CONS 
5 B/O SANGEETHA 34-36 72 M 1.8 LETHARGY,ROF,SKIN 
MOTTLING 
4 7.6 0.4 14800 3.2 - - - - PSEUDOMONAS 
6 B/O KAVITHA 28-30 1 F 1 PPROM >60HRS 2 6.8 0.51 17000 2.3 - - - - K. PNEUMONEA 
7 B/O CHITRA ≥37 168 F 2.6 LETHARGY,ROF 12 0.09 4.1 12700 1.9 - - - - K. PNEUMONEA 
8 B/O RADHAMANI ≥37 96 F 2.7 ROF, SEIZURE 18 2.59 2.1 15600 3.4 - - - - K. PNEUMONEA 
9 B/O SUMATHI ≥37 120 M 2.8 ROF, SEIZURE 6 17.8 0.52 4500 5.8 - 120 370 - K. PNEUMONEA 
10 B/O MYELATHAL ≥37 72 M 1.8 LETHARGY,ROF 12 2.6 3.8 17600 0.84 - - - - ENTEROBACTER 
11 B/O VIJI 34-36 120 F 1.6 ABDOMEN 
DISTENSION,ALTERED 
VOMITUS,LETHARGY 
10 24.6 3.4 7200 0.47 - - - - K. PNEUMONEA 
12 B/O SAGUNTHALA ≥37 72 F 2.2 LETHARGY,ROF 7 54 7.9 14800 1.68 - - - - PSEUDOMONAS 
13 B/O SUMATHI ≥37 120 F 2.8 LETHARGY,ROF 22 3.7 0.4 4500 2.62 - - - - K. PNEUMONEA 
14 B/O SINDU 34-36 192 F 1.7 LETHARGY,ROF 6 21.5 0.5 3500 0.81 - - - - K. PNEUMONEA 
15 B/O JEYANTHI 32-34 360 M 1.5 RDS,ROF 7 3.8 8.2 7900 3.20 PNEUMONIA - - - CONS 
16 B/O MALATHI 34-36 1 F 2.1 PROM 4DAYS,FOUL  SMELLING 
LIQOR 
1 17.3 0.4 9200 2.6 - - - - K. PNEUMONEA 
17 B/O RADHA ≥37 72 M 1.9 ROF,FEVER 12 8.2 10.02 11600 0.21 - - - - K. PNEUMONEA 
18 B/O GAYATHRI ≥37 408 F 3.3 RDS, ROF, FEVER 18 5.8 4.9 31700 3.93 PNEUMONIA - - - ENTEROBACTER 
19 B/O VINODHINI ≥37 18 M 2.9 PROM >48 HRS,RDS 18 4.9 3.3 15000 4.12 - - - - ENTERCOCCUS 
20 B/O ANNALAKSHMI 32-34 1 M 1.4 PPROM >24HRS 1 6.8 0.4 6800 0.3 - - - - K. PNEUMONEA 
21 B/O INDRANI 28-30 6 F 0.9 PPROM >24HRS 6 5.9 0.3 2500 0.07 - - - - ENTEROBACTER 
22 B/O KALPANA 34-36 72 M 1.7 RDS, SEIZURE 6 46.2 12.5 14000 1.64 - - - - CONS 
23 B/O POORNIMA ≥37 2 M 2.6 PROM > 48HRS 2 3.2 0.09 17500 2.22 - - - - K. PNEUMONEA 
24 B/O UMADEVI ≥37 72 F 3 LETHARGY,ROF 12 0.8 4 6000 0.53 - - - - K. PNEUMONEA 
25 B/O LEELAVATHI ≥37 480 M 4 RDS, ROF 6 2.3 0.7 26000 1.95 PNEUMONIA - - - K. PNEUMONEA 
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S.NO 
 
NAME 
 
GEST 
AGE 
 
AGE 
 
SEX 
 
WT 
KG 
 
SYMPTOMS 
 
SAMP 
INTVL 
 
PCT 
NG/DL 
 
CRP 
MG/DL 
 
WBC 
/CUMM 
 
PLT 
L/CUMM 
 
CXR 
 
CSF 
 
 
OTHERS 
 
BLOOD 
CULTURE 
 
 
CELLS/DL 
 
PROTEIN 
MG/DL 
26 B/O SUDHA ≥37 168 M 1.9 LETHARGY, SEIZURE 18 2.7 9.4 3200 0.08 - 80 220 - CONS 
27 B/O KALAIVANI ≥37 216 F 2.6 RDS, ROF 12 17 8.9 24000 2.90 - - - - K. PNEUMONEA 
28 B/O SATHYAPRIYA ≥37 144 M 3 LETHARGY,ROF 13 7.56 10.5 1300 0.64 - 500 H.V - - 
29 B/O HEMALATHA ≥37 168 F 2.8 RDS 24 1.07 5.5 23000 1.83 PNEUMONIA - - - - 
30 B/O DEVASHREE ≥37 480 M 3.2 RDS, ROF 18 1.7 10.28 26000 3.86 PNEUMONIA - - - - 
31 B/O JULIANACRISTI ≥37 96 M 2.3 RDS, ROF 12 2.9 0.42 15300 0.82 PNEUMONIA - - - - 
32 B/O PALANIAMMAL ≥37 144 M 3 ROF, SEIZURE 7 0.3 0.4 4300 2.16 - 420 H.V - - 
33 B/O RASIDABEGUM ≥37 72 M 3 LETHARGY, SEIZURE 6 15.2 0.32 16300 2.75 - 60 185 - - 
34 B/O KAVITHA ≥37 312 F 4 RDS, FEVER 24 13.2 4.8 50000 1.62 PNEUMONIA - - CT THORAX-
CONSOLIDATION 
- 
35 B/O SUDHA ≥37 72 M 2.2 FEVER,ROF,RT KNEE SWELLING 12 0.8 10.28 10000 1.92 - - - USG-JT EFFUSION 
3ML PUS ASP 
- 
36 B/O DEEPA ≥37 42 M 3.2 ROF,LETHARGY, SEIZURE 4 4.2 0.06 11700 2.31 - 80 225 - - 
37 ROHITH ≥37 504 M 2 RDS,LOOSE STOOLS 28 57.9 3.8 29700 2.61 PNEUMONIA - - - - 
38 B/O CHITRA ≥37 72 F 2.4 RDS 6 7.2 0.5 9700 1.75 PNEUMONIA - - - - 
39 B/O KRISHNAVENI ≥37 46 M 3.2 RDS 5 4.8 0.6 26000 3.12 PNEUMONIA - - - - 
40 B/O SUGANYA ≥37 360 M 2.8 RDS, ROF 18 0.3 0.32 6900 1.91 PNEUMONIA - - - - 
41 B/O VAIRAPRIYA ≥37 384 F 3 LETHARGY,ROF, RDS 18 0.8 3.2 6800 3.32 PNEUMONIA - - - - 
42 B/O BANUMATHI ≥37 552 M 2.1 LETHARGY,ROF, SEIZURE 16 2.37 6.3 3200 4.20 - 200 H.V - - 
43 B/O MADHUMATHI ≥37 120 F 2.5 LETHARGY,ROF 10 1.85 4.7 23000 0.62 - - - - - 
44 B/O PARAMESWARI ≥37 38 F 2 LETHARGY,ROF 8 1.47 0.5 8300 2.80 - - - - - 
45 B/O TULASIMANI ≥37 72 F 3.8 ROF, ABDOMEN DISTENSION 6 9.2 3.8 27000 0.27 - - - - - 
46 B/O CHANDRADEVI ≥37 72 M 1.9 ROF, ABDOMEN DISTENSION 12 1.3 0.4 4100 2.36 - - - - - 
47 B/O SITAARA 32-34 1 M 1.3 PROM >48HRS 1 0.9 0.5 13000 2.58 - - - - - 
48 B/O PUNITHA ≥37 120 F 2.6 ROF, ABDOMEN DISTENSION 12 1.9 0.3 12000 3.42 - - - - - 
49 B/O PODUMPONU ≥37 144 F 1.9 LETHARGY,ROF 18 0.8 0.7 6000 5.26 - - - - - 
50 B/O SANGEETHA ≥37 36 F 2.3 SKIN MOTTLING 8 0.37 0.4 6000 1.24 - - - - - 
 
 
                                          ABSTRACT 
OBJECTIVE:  To determine usefulness of procalcitonin as  an early and 
reliable marker of sepsis and to compare its efficacy with C-reactive protein and 
WBC count in predicting neonatal sepsis. 
METHOD: A total of 50 neonates with features or risks of sepsis were included 
in the study. Blood samples were drawn for procalcitonin, CRP, WBC count 
and blood culture before starting antibiotics. Neonates were divided into three 
groups based on blood culture and other investigations like CSF analysis, chest 
x-ray, as culture positive sepsis (27), culture negative sepsis (15), and suspected 
sepsis (23). The diagnostic value of procalcitonin was calculated using blood 
culture as gold standard investigation and compared with diagnostic value of 
CRP and WBC count.  
RESULTS:  Serum levels of PCT were significantly higher in culture positive 
group. The sensitivity, specificity, positive predictive value and negative 
predictive value of PCT were 92.59%, 56.52%, 71.4% and 86.6% respectively. 
The sensitivity, specificity, positive predictive value and negative predictive 
value for CRP were 55.55%, 56.52%, 60% and 52% respectively. The 
Sensitivity, specificity, positive predictive value and negative predictive value 
for WBC count were 40.74%, 52.17%, 50% and 42.85% respectively. 
CONCLUSION: Procalcitonin can be used as an early and reliable marker of 
neonatal sepsis. CRP and WBC count though can be used as initial sepsis 
screening; they cannot be substituted for procalcitonin. No combined 
investigation excluding procalcitonin was superior to procalcitonin. 
 
 
